정밀의료용 공급망 물류 시장 : 규모, 점유율, 동향 분석 보고서 - 유형별, 서비스별, 온도 범위별, 용도별, 제품별, 최종 용도별, 지역별 부문 예측(2025-2030년)

Precision Medicine Supply Chain Logistics Market Growth & Trends:

The global precision medicine supply chain logistics market size is expected to reach USD 14.12 billion by 2030, growing at a CAGR of 11.36% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is primarily attributed to the rapid technological advancements, the increasing number of clinical trials, higher approval of precision medicines, and a stringent regulatory framework. In addition, the increasing focus on regulatory compliance towards ensuring the products are handled safely and securely further boosting market growth.

The growth of the precision medicine supply chain logistics industry is driven by the rising demand for personalized medicine, which necessitates highly specialized logistics solutions. As healthcare shifts towards more individualized treatments, precision medicines such as gene therapies, biologics, and personalized drugs require tailored logistics solutions that ensure temperature-controlled transportation, regulatory compliance, and real-time tracking. This shift has created a growing need for end-to-end supply chain management solutions that can handle complex and sensitive products. Advanced technologies such as IoT-based tracking systems, temperature sensors, and blockchain for data transparency are becoming critical for maintaining the integrity of these products throughout the distribution process.

The market growth is also supported by the increasing trend of outsourcing logistics functions to third-party providers, enabling pharmaceutical companies and healthcare organizations to focus on core competencies such as R&D and product development. As the complexity of supply chains grows, outsourcing helps organizations manage logistics more effectively, reducing operational costs and improving scalability. Stringent regulatory requirements, particularly in handling biologics and genetic materials, further contribute to the demand for specialized logistics services that can ensure compliance with local and international regulations. Furthermore, the rise of e-commerce platforms and direct-to-consumer delivery models is expanding the scope of precision medicine logistics, requiring innovative solutions to manage the direct shipment of personalized therapies to patients. These factors are collectively driving the market growth, offering a substantial opportunity for logistics providers to capitalize on this emerging sector.

Rising initiatives by market players play a pivotal role in shaping the precision medicine supply chain logistics landscape. Leading logistics providers and pharmaceutical companies are investing in cutting-edge technologies and infrastructure to enhance the efficiency and reliability of supply chains for personalized treatments. Strategic partnerships and collaborations are being formed to address challenges related to temperature-sensitive shipments, regulatory compliance, and secure data handling. Companies are increasingly focusing on developing integrated logistics solutions that offer end-to-end visibility and real-time monitoring, improving overall supply chain transparency. For instance, in April 2025, GXO initiated a program to test humanoid robots in its warehouses, aiming to integrate advanced AI-driven automation into its operations. The company is currently piloting robots from Agility Robotics, Apptronik, and Reflex Robotics, each performing specific tasks such as moving containers and recycling materials.

Precision Medicine Supply Chain Logistics Market Report Highlights:

• Based on type, the clinical segment dominated the market in 2024, due to an increasing number of research and development activities by the market players, coupled with the growing number of precision medicine therapies in product pipelines.
• Based on service, the transportation segment dominated the market in 2024. The growth of is largely attributed to the rising demand for efficient, secure, and compliant transportation solutions capable of handling biologics, cell & gene therapies, and personalized medications.
• Based on temperature range, ambient storage held the largest revenue share in 2024 due to the increasing demand for cell & gene therapies, biologics, and regenerative medicine products that do not require ultra-low or cryogenic temperatures.
• Based on application, the oncology segment dominated the precision medicine supply chain logistics industry in 2024, due to the rapid adoption of advanced therapies for treating various cancers, particularly hematologic malignancies and solid tumors.
• Based on product, the cell & gene therapies segment held a dominant revenue share in 2024, due to the rapid advancements in personalized medicine and the increasing adoption of these therapies for a range of complex diseases.
• Based on end use, pharmaceutical and biopharmaceutical companies held the largest market share in 2024, due to the increasing focus on personalized therapies, including cell and gene therapies, mRNA-based treatments, and other high-value biologics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Information Analysis
  • 1.4.2. Market Formulation & Data Visualization
  • 1.4.3. Data Validation & Publishing
• 1.5. Model Details
  • 1.5.1. Commodity Flow Analysis (Model 1)
  • 1.5.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.5.3. Multivariate Analysis (Model 3)
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Precision Medicine Supply Chain Logistics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Adoption of Precision Medicine
    • 3.2.1.2. Increasing Clinical Trials for Personalized Therapeutics
    • 3.2.1.3. Regulatory Emphasis on Traceability and Quality Compliance
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Specialized Infrastructure and Operational Complexity
    • 3.2.2.2. Limited Standardization and Interoperability Across Supply Chains
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. Industry Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Precision Medicine Supply Chain Logistics Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Precision Medicine Supply Chain Logistics Market Type Movement Analysis
• 4.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Clinical
  • 4.4.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Commercial
  • 4.5.1. Commercial market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Precision Medicine Supply Chain Logistics Market: Service Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Precision Medicine Supply Chain Logistics Market Service Movement Analysis
• 5.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
• 5.4. Transportation
  • 5.4.1. Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Air Freight
    • 5.4.2.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.2. Sea Freight
      • 5.4.2.2.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2.3. Overland
      • 5.4.2.3.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Warehousing
  • 5.5.1. Warehousing market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Sourcing & Procurement
  • 5.6.1. Sourcing & Procurement market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Precision Medicine Supply Chain Logistics Market: Temperature Range Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Precision Medicine Supply Chain Logistics Market Temperature Range Movement Analysis
• 6.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
• 6.4. Ambient Storage
  • 6.4.1. Ambient storage market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Refrigerated Storage
  • 6.5.1. Refrigerated storage market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Ultra-Low Temperature Storage
  • 6.6.1. Ultra-low temperature storage market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Cryogenic Storage
  • 6.7.1. Cryogenic storage market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Precision Medicine Supply Chain Logistics Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Precision Medicine Supply Chain Logistics Market Application Movement Analysis
• 7.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Oncology
  • 7.4.1. Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Cardiology
  • 7.5.1. Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Neurology
  • 7.6.1. Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Infectious Diseases
  • 7.7.1. Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. Rare Diseases
  • 7.8.1. Rare diseases market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.9. Others
  • 7.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Precision Medicine Supply Chain Logistics Market: Product Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Precision Medicine Supply Chain Logistics Market Product Movement Analysis
• 8.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 8.4. Cell & Gene Therapies (CGT)
  • 8.4.1. Cell & Gene Therapies (CGT) market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Monoclonal Antibodies
  • 8.5.1. Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Nucleic Acid Therapies
  • 8.6.1. Nucleic acid therapies market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. Vaccines
  • 8.7.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.8. Others
  • 8.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Precision Medicine Supply Chain Logistics Market: End Use Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Global Precision Medicine Supply Chain Logistics Market End Use Movement Analysis
• 9.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 9.4. Pharmaceutical and Biopharmaceutical Companies
  • 9.4.1. Pharmaceutical and biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.5. Clinical Research Organizations
  • 9.5.1. Clinical research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.6. Others
  • 9.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Precision Medicine Supply Chain Logistics Market: Regional Estimates & Trend Analysis

• 10.1. Regional Market Share Analysis, 2024 & 2030
• 10.2. Regional Market Dashboard
• 10.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
• 10.4. North America
  • 10.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.4.2. U.S.
    • 10.4.2.1. Key country dynamics
    • 10.4.2.2. Competitive scenario
    • 10.4.2.3. Regulatory framework
    • 10.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.4.3. Canada
    • 10.4.3.1. Key country dynamics
    • 10.4.3.2. Competitive scenario
    • 10.4.3.3. Regulatory framework
    • 10.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.4.4. Mexico
    • 10.4.4.1. Key country dynamics
    • 10.4.4.2. Competitive scenario
    • 10.4.4.3. Regulatory framework
    • 10.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.5. Europe
  • 10.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.2. UK
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. Competitive scenario
    • 10.5.2.3. Regulatory framework
    • 10.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.3. Germany
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. Competitive scenario
    • 10.5.3.3. Regulatory framework
    • 10.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.4. France
    • 10.5.4.1. Key country dynamics
    • 10.5.4.2. Competitive scenario
    • 10.5.4.3. Regulatory framework
    • 10.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.5. Italy
    • 10.5.5.1. Key country dynamics
    • 10.5.5.2. Competitive scenario
    • 10.5.5.3. Regulatory framework
    • 10.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.6. Spain
    • 10.5.6.1. Key country dynamics
    • 10.5.6.2. Competitive scenario
    • 10.5.6.3. Regulatory framework
    • 10.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.7. Denmark
    • 10.5.7.1. Key country dynamics
    • 10.5.7.2. Competitive scenario
    • 10.5.7.3. Regulatory framework
    • 10.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.8. Norway
    • 10.5.8.1. Key country dynamics
    • 10.5.8.2. Competitive scenario
    • 10.5.8.3. Regulatory framework
    • 10.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.5.9. Sweden
    • 10.5.9.1. Key country dynamics
    • 10.5.9.2. Competitive scenario
    • 10.5.9.3. Regulatory framework
    • 10.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.6. Asia Pacific
  • 10.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.2. Japan
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Competitive scenario
    • 10.6.2.3. Regulatory framework
    • 10.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.3. China
    • 10.6.3.1. Key country dynamics
    • 10.6.3.2. Competitive scenario
    • 10.6.3.3. Regulatory framework
    • 10.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.4. India
    • 10.6.4.1. Key country dynamics
    • 10.6.4.2. Competitive scenario
    • 10.6.4.3. Regulatory framework
    • 10.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.5. Australia
    • 10.6.5.1. Key country dynamics
    • 10.6.5.2. Competitive scenario
    • 10.6.5.3. Regulatory framework
    • 10.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.6. South Korea
    • 10.6.6.1. Key country dynamics
    • 10.6.6.2. Competitive scenario
    • 10.6.6.3. Regulatory framework
    • 10.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.6.7. Thailand
    • 10.6.7.1. Key country dynamics
    • 10.6.7.2. Competitive scenario
    • 10.6.7.3. Regulatory framework
    • 10.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.7. Latin America
  • 10.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 10.7.2. Brazil
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Competitive scenario
    • 10.7.2.3. Regulatory framework
    • 10.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.7.3. Argentina
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. Competitive scenario
    • 10.7.3.3. Regulatory framework
    • 10.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• 10.8. MEA
  • 10.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 10.8.2. South Africa
    • 10.8.2.1. Key country dynamics
    • 10.8.2.2. Competitive scenario
    • 10.8.2.3. Regulatory framework
    • 10.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.8.3. Saudi Arabia
    • 10.8.3.1. Key country dynamics
    • 10.8.3.2. Competitive scenario
    • 10.8.3.3. Regulatory framework
    • 10.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.8.4. UAE
    • 10.8.4.1. Key country dynamics
    • 10.8.4.2. Competitive scenario
    • 10.8.4.3. Regulatory framework
    • 10.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • 10.8.5. Kuwait
    • 10.8.5.1. Key country dynamics
    • 10.8.5.2. Competitive scenario
    • 10.8.5.3. Regulatory framework
    • 10.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Competition Categorization
  • 11.1.1. Market Leaders
  • 11.1.2. Emerging players
• 11.2. Company Market Share/Assessment Analysis, 2024
• 11.3. Company Profiles
  • 11.3.1. Almac Group
    • 11.3.1.1. Company overview
    • 11.3.1.2. Financial performance
    • 11.3.1.3. Service benchmarking
    • 11.3.1.4. Strategic initiatives
  • 11.3.2. Catalent, Inc
    • 11.3.2.1. Company overview
    • 11.3.2.2. Financial performance
    • 11.3.2.3. Service benchmarking
    • 11.3.2.4. Strategic initiatives
  • 11.3.3. Parexel International
    • 11.3.3.1. Company overview
    • 11.3.3.2. Financial performance
    • 11.3.3.3. Service benchmarking
    • 11.3.3.4. Strategic initiatives
  • 11.3.4. IQVIA
    • 11.3.4.1. Company overview
    • 11.3.4.2. Financial performance
    • 11.3.4.3. Service benchmarking
    • 11.3.4.4. Strategic initiatives
  • 11.3.5. Thermo Fisher Scientific
    • 11.3.5.1. Company overview
    • 11.3.5.2. Financial performance
    • 11.3.5.3. Service benchmarking
    • 11.3.5.4. Strategic initiatives
  • 11.3.6. DHL
    • 11.3.6.1. Company overview
    • 11.3.6.2. Financial performance
    • 11.3.6.3. Service benchmarking
    • 11.3.6.4. Strategic initiatives
  • 11.3.7. FedEx
    • 11.3.7.1. Company overview
    • 11.3.7.2. Financial performance
    • 11.3.7.3. Service benchmarking
    • 11.3.7.4. Strategic initiatives
  • 11.3.8. UPS Healthcare
    • 11.3.8.1. Company overview
    • 11.3.8.2. Financial performance
    • 11.3.8.3. Service benchmarking
    • 11.3.8.4. Strategic initiatives
  • 11.3.9. GXO Logistics
    • 11.3.9.1. Company overview
    • 11.3.9.2. Financial performance
    • 11.3.9.3. Service benchmarking
    • 11.3.9.4. Strategic initiatives
  • 11.3.10. Marken
    • 11.3.10.1. Company overview
    • 11.3.10.2. Financial performance
    • 11.3.10.3. Service benchmarking
    • 11.3.10.4. Strategic initiatives